232 related articles for article (PubMed ID: 33790404)
1. Enhancing calmodulin binding to ryanodine receptor is crucial to limit neuronal cell loss in Alzheimer disease.
Nakamura Y; Yamamoto T; Xu X; Kobayashi S; Tanaka S; Tamitani M; Saito T; Saido TC; Yano M
Sci Rep; 2021 Mar; 11(1):7289. PubMed ID: 33790404
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of ryanodine receptor (RyR) and calmodulin enhance Ca release and pathologically alter, RyR structure and calmodulin affinity.
Oda T; Yang Y; Uchinoumi H; Thomas DD; Chen-Izu Y; Kato T; Yamamoto T; Yano M; Cornea RL; Bers DM
J Mol Cell Cardiol; 2015 Aug; 85():240-8. PubMed ID: 26092277
[TBL] [Abstract][Full Text] [Related]
3. Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease.
Oulès B; Del Prete D; Greco B; Zhang X; Lauritzen I; Sevalle J; Moreno S; Paterlini-Bréchot P; Trebak M; Checler F; Benfenati F; Chami M
J Neurosci; 2012 Aug; 32(34):11820-34. PubMed ID: 22915123
[TBL] [Abstract][Full Text] [Related]
4. Ryanodine receptor-bound calmodulin is essential to protect against catecholaminergic polymorphic ventricular tachycardia.
Nakamura Y; Yamamoto T; Kobayashi S; Tamitani M; Hamada Y; Fukui G; Xu X; Nishimura S; Kato T; Uchinoumi H; Oda T; Okuda S; Yano M
JCI Insight; 2019 Jun; 4(11):. PubMed ID: 31167968
[TBL] [Abstract][Full Text] [Related]
5. Nuclear translocation of calmodulin in pathological cardiac hypertrophy originates from ryanodine receptor bound calmodulin.
Oda T; Yamamoto T; Kato T; Uchinoumi H; Fukui G; Hamada Y; Nanno T; Ishiguchi H; Nakamura Y; Okamoto Y; Kono M; Okuda S; Kobayashi S; Bers DM; Yano M
J Mol Cell Cardiol; 2018 Dec; 125():87-97. PubMed ID: 30359562
[TBL] [Abstract][Full Text] [Related]
6. Stabilizing ER Ca2+ channel function as an early preventative strategy for Alzheimer's disease.
Chakroborty S; Briggs C; Miller MB; Goussakov I; Schneider C; Kim J; Wicks J; Richardson JC; Conklin V; Cameransi BG; Stutzmann GE
PLoS One; 2012; 7(12):e52056. PubMed ID: 23284867
[TBL] [Abstract][Full Text] [Related]
7. The Arrhythmogenic Calmodulin p.Phe142Leu Mutation Impairs C-domain Ca2+ Binding but Not Calmodulin-dependent Inhibition of the Cardiac Ryanodine Receptor.
Søndergaard MT; Liu Y; Larsen KT; Nani A; Tian X; Holt C; Wang R; Wimmer R; Van Petegem F; Fill M; Chen SR; Overgaard MT
J Biol Chem; 2017 Jan; 292(4):1385-1395. PubMed ID: 27927985
[TBL] [Abstract][Full Text] [Related]
8. Amyloid β production is regulated by β2-adrenergic signaling-mediated post-translational modifications of the ryanodine receptor.
Bussiere R; Lacampagne A; Reiken S; Liu X; Scheuerman V; Zalk R; Martin C; Checler F; Marks AR; Chami M
J Biol Chem; 2017 Jun; 292(24):10153-10168. PubMed ID: 28476886
[TBL] [Abstract][Full Text] [Related]
9. Post-translational remodeling of ryanodine receptor induces calcium leak leading to Alzheimer's disease-like pathologies and cognitive deficits.
Lacampagne A; Liu X; Reiken S; Bussiere R; Meli AC; Lauritzen I; Teich AF; Zalk R; Saint N; Arancio O; Bauer C; Duprat F; Briggs CA; Chakroborty S; Stutzmann GE; Shelanski ML; Checler F; Chami M; Marks AR
Acta Neuropathol; 2017 Nov; 134(5):749-767. PubMed ID: 28631094
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure.
Ono M; Yano M; Hino A; Suetomi T; Xu X; Susa T; Uchinoumi H; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Koseki N; Kyushiki H; Ikemoto N; Matsuzaki M
Cardiovasc Res; 2010 Sep; 87(4):609-17. PubMed ID: 20388639
[TBL] [Abstract][Full Text] [Related]
11. CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift.
Uchinoumi H; Yang Y; Oda T; Li N; Alsina KM; Puglisi JL; Chen-Izu Y; Cornea RL; Wehrens XHT; Bers DM
J Mol Cell Cardiol; 2016 Sep; 98():62-72. PubMed ID: 27318036
[TBL] [Abstract][Full Text] [Related]
12. Stabilizing cardiac ryanodine receptor prevents the development of cardiac dysfunction and lethal arrhythmia in Ca
Sufu-Shimizu Y; Okuda S; Kato T; Nishimura S; Uchinoumi H; Oda T; Kobayashi S; Yamamoto T; Yano M
Biochem Biophys Res Commun; 2020 Apr; 524(2):431-438. PubMed ID: 32007269
[TBL] [Abstract][Full Text] [Related]
13. Enhancing calmodulin binding to cardiac ryanodine receptor completely inhibits pressure-overload induced hypertrophic signaling.
Kohno M; Kobayashi S; Yamamoto T; Yoshitomi R; Kajii T; Fujii S; Nakamura Y; Kato T; Uchinoumi H; Oda T; Okuda S; Watanabe K; Mizukami Y; Yano M
Commun Biol; 2020 Nov; 3(1):714. PubMed ID: 33244105
[TBL] [Abstract][Full Text] [Related]
14. Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction.
Xu X; Yano M; Uchinoumi H; Hino A; Suetomi T; Ono M; Tateishi H; Oda T; Okuda S; Doi M; Kobayashi S; Yamamoto T; Ikeda Y; Ikemoto N; Matsuzaki M
Biochem Biophys Res Commun; 2010 Apr; 394(3):660-6. PubMed ID: 20226167
[TBL] [Abstract][Full Text] [Related]
15. Diminished inhibition and facilitated activation of RyR2-mediated Ca
Søndergaard MT; Liu Y; Brohus M; Guo W; Nani A; Carvajal C; Fill M; Overgaard MT; Chen SRW
FEBS J; 2019 Nov; 286(22):4554-4578. PubMed ID: 31230402
[TBL] [Abstract][Full Text] [Related]
16. RyR2-targeting therapy prevents left ventricular remodeling and ventricular tachycardia in post-infarction heart failure.
Fujii S; Kobayashi S; Chang Y; Nawata J; Yoshitomi R; Tanaka S; Kohno M; Nakamura Y; Ishiguchi H; Suetomi T; Uchinoumi H; Oda T; Okuda S; Okamura T; Yamamoto T; Yano M
J Mol Cell Cardiol; 2023 May; 178():36-50. PubMed ID: 36963751
[TBL] [Abstract][Full Text] [Related]
17. Altered RyR2 regulation by the calmodulin F90L mutation associated with idiopathic ventricular fibrillation and early sudden cardiac death.
Nomikos M; Thanassoulas A; Beck K; Vassilakopoulou V; Hu H; Calver BL; Theodoridou M; Kashir J; Blayney L; Livaniou E; Rizkallah P; Nounesis G; Lai FA
FEBS Lett; 2014 Aug; 588(17):2898-902. PubMed ID: 25036739
[TBL] [Abstract][Full Text] [Related]
18. NMDA-mediated Ca(2+) influx drives aberrant ryanodine receptor activation in dendrites of young Alzheimer's disease mice.
Goussakov I; Miller MB; Stutzmann GE
J Neurosci; 2010 Sep; 30(36):12128-37. PubMed ID: 20826675
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic Calmodulin Mutations Affect the Activation and Termination of Cardiac Ryanodine Receptor-mediated Ca2+ Release.
Søndergaard MT; Tian X; Liu Y; Wang R; Chazin WJ; Chen SR; Overgaard MT
J Biol Chem; 2015 Oct; 290(43):26151-62. PubMed ID: 26309258
[TBL] [Abstract][Full Text] [Related]
20. RyR2-dependent modulation of neuronal hyperactivity: A potential therapeutic target for treating Alzheimer's disease.
Yao J; Chen SRW
J Physiol; 2024 Apr; 602(8):1509-1518. PubMed ID: 36866974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
